AI prescription renewals test regulatory boundaries
The report framed Utah's experiment with AI-driven prescription renewals as a novel, cost-saving initiative that is expanding rapidly but raises questions about medical accountability and scope creep.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.